Status:
COMPLETED
The Role of Erythropoietin in Myelodysplastic Syndrome
Lead Sponsor:
University of Utah
Collaborating Sponsors:
National Institutes of Health (NIH)
Conditions:
Myelodysplastic Syndrome
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of the study is to elucidate the causative molecular events responsible for the abnormal erythropoiesis in MDS.
Detailed Description
Myelodysplastic syndromes are a heterogeneous group of disorders characterized by clonal expansion of hematopoietic stem cells and ineffective hematopoiesis. Although all 3 cell lineages in myeloid he...
Eligibility Criteria
Inclusion
- Adult subjects greater than 18 years of age
- Diagnosis of MDS based on the French-American-British classification system (including secondary causes of MDS)
Exclusion
- Subjects not meeting the criteria listed above
Key Trial Info
Start Date :
February 1 2007
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 1 2010
Estimated Enrollment :
8 Patients enrolled
Trial Details
Trial ID
NCT00723112
Start Date
February 1 2007
End Date
October 1 2010
Last Update
November 23 2010
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Utah
Salt Lake City, Utah, United States, 84132
2
VA Salt Lake City Health Care System
Salt Lake City, Utah, United States, 84148